Avanos Medical (AVNS) Change in Accured Expenses (2013 - 2026)

Avanos Medical has reported Change in Accured Expenses for 14 years, with the latest figure at -$33.7 million in Q1 2026.

• Quarterly Change in Accured Expenses fell 127.7% year-over-year to -$33.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$31.8 million (down 2371.43% YoY) and the FY2025 annual result came in at -$12.9 million, down 13.16% from the prior year.
• Change in Accured Expenses fell to -$33.7 million in Q1 2026 per AVNS's latest filing, from $9.5 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $17.4 million in Q3 2023 and troughed at -$33.7 million in Q1 2026.
• A 5-year average of -$5.5 million and a median of -$7.2 million in 2025 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2023 and 2024: Change in Accured Expenses plunged 3300.0% in 2023, then surged 276.04% in 2024.
• Over 5 years, Change in Accured Expenses stood at $11.4 million in 2022, then slumped by 170.18% to -$8.0 million in 2023, then increased by 3.75% to -$7.7 million in 2024, then surged by 223.38% to $9.5 million in 2025, then slumped by 454.74% to -$33.7 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$33.7 million, $9.5 million, and -$400000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.